Perioperative Management of Extended-release Buprenorphine
- PMID: 35862898
- DOI: 10.1097/ADM.0000000000001024
Perioperative Management of Extended-release Buprenorphine
Abstract
Perioperative management of buprenorphine is increasingly characterized by continuation of buprenorphine throughout the perioperative period while coadministering full agonist opioids for analgesia. Although this "simultaneous strategy" is commonly used for the shorter-acting sublingual buprenorphine formulations, there is little to guide management of the extended-release formulations of buprenorphine. Here we report the perioperative experience of an individual maintained on extended-release buprenorphine who successfully underwent major surgeries utilizing a strategy of performing the surgeries at the time of the next scheduled dose.
Copyright © 2022 American Society of Addiction Medicine.
References
-
- Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS). Data on Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2020; 2021.
-
- Webster L, Gudin J, Raffa RB, et al. Understanding buprenorphine for use in chronic pain: Expert opinion. Pain Med 2020;21(4):714–723.
-
- Coe MA, Lofwall MR, Walsh SL. Buprenorphine pharmacology review: Update on transmucosal and long-acting formulations. J Addict Med 2019;13(2):93–103.
-
- Lamim Ribeiro JM, Provasi D, Filizola M. A combination of machine learning and infrequent metadynamics to efficiently predict kinetic rates, transition states, and molecular determinants of drug dissociation from G protein–coupled receptors. J Chem Phys 2020;153(12):124105.
-
- Buresh M, Ratner J, Zgierska A, et al. Treating perioperative and acute pain in patients on buprenorphine: Narrative literature review and practice recommendations. J Gen Intern Med 2020;35(12):3635–3643.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical